Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antibody Fragments market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antibody Fragmentsmarket, defines the market attractiveness level of Antibody Fragments market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antibody Fragments industry, describes the types of Antibody Fragments market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibody Fragments market and the development prospects and opportunities of Antibody Fragments industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibody Fragments market in Chapter 13.
By Player:
Biogen
Amgen
Takeda Pharmaceutical
AbbVie
Bristol-Myers Squibb
Eli Lilly
Novartis
Sanofi
F Hoffmann-La Roche
Johnson & Johnson
By Type:
F(ab) Fragment
F(ab’)2 Fragment
By End-User:
Cancer
Immunodeficiencies
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antibody Fragments Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antibody Fragments Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antibody Fragments Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antibody Fragments Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antibody Fragments Market Analysis and Outlook to 2022
-
7.1 Global Antibody Fragments Consumption (2017-2022)
-
7.2 United States Antibody Fragments Consumption (2017-2022)
-
7.3 Europe Antibody Fragments Consumption (2017-2022)
-
7.4 China Antibody Fragments Consumption (2017-2022)
-
7.5 Japan Antibody Fragments Consumption (2017-2022)
-
7.6 India Antibody Fragments Consumption (2017-2022)
-
7.7 South Korea Antibody Fragments Consumption (2017-2022)
8 Region and Country-wise Antibody Fragments Market Analysis and Outlook to 2028
-
8.1 Global Antibody Fragments Consumption Forecast (2022-2028)
-
8.2 United States Antibody Fragments Consumption Forecast (2022-2028)
-
8.3 Europe Antibody Fragments Consumption Forecast (2022-2028)
-
8.4 China Antibody Fragments Consumption Forecast (2022-2028)
-
8.5 Japan Antibody Fragments Consumption Forecast (2022-2028)
-
8.6 India Antibody Fragments Consumption Forecast (2022-2028)
-
8.7 South Korea Antibody Fragments Consumption Forecast (2022-2028)
9 Global Antibody Fragments Market Outlook by Types and Applications to 2022
-
9.1 Global Antibody Fragments Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global F(ab) Fragment Consumption and Growth Rate (2017-2022)
-
9.1.2 Global F(ab’)2 Fragment Consumption and Growth Rate (2017-2022)
-
9.2 Global Antibody Fragments Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Immunodeficiencies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antibody Fragments Market Outlook by Types and Applications to 2028
-
10.1 Global Antibody Fragments Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global F(ab) Fragment Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global F(ab’)2 Fragment Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antibody Fragments Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Immunodeficiencies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antibody Fragments Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antibody Fragments Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antibody Fragments Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antibody Fragments Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antibody Fragments Market Competitive Analysis
-
14.1 Biogen
-
14.1.1 Biogen Company Details
-
14.1.2 Biogen Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Biogen Antibody Fragments Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Antibody Fragments Product and Service
-
14.3 Takeda Pharmaceutical
-
14.3.1 Takeda Pharmaceutical Company Details
-
14.3.2 Takeda Pharmaceutical Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Takeda Pharmaceutical Antibody Fragments Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Antibody Fragments Product and Service
-
14.5 Bristol-Myers Squibb
-
14.5.1 Bristol-Myers Squibb Company Details
-
14.5.2 Bristol-Myers Squibb Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Antibody Fragments Product and Service
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Details
-
14.6.2 Eli Lilly Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly Antibody Fragments Product and Service
-
14.7 Novartis
-
14.7.1 Novartis Company Details
-
14.7.2 Novartis Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novartis Antibody Fragments Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Antibody Fragments Product and Service
-
14.9 F Hoffmann-La Roche
-
14.9.1 F Hoffmann-La Roche Company Details
-
14.9.2 F Hoffmann-La Roche Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 F Hoffmann-La Roche Antibody Fragments Product and Service
-
14.10 Johnson & Johnson
-
14.10.1 Johnson & Johnson Company Details
-
14.10.2 Johnson & Johnson Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Johnson & Johnson Antibody Fragments Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antibody Fragments
-
Figure Antibody Fragments Picture
-
Table Global Antibody Fragments Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Fragments Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Fragments Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antibody Fragments Consumption by Country (2017-2022)
-
Figure United States Antibody Fragments Consumption and Growth Rate (2017-2022)
-
Table Europe Antibody Fragments Consumption and Growth Rate (2017-2022)
-
Figure China Antibody Fragments Consumption and Growth Rate (2017-2022)
-
Figure Japan Antibody Fragments Consumption and Growth Rate (2017-2022)
-
Figure India Antibody Fragments Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antibody Fragments Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Fragments Consumption Forecast by Country (2022-2028)
-
Figure United States Antibody Fragments Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antibody Fragments Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antibody Fragments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antibody Fragments Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antibody Fragments Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antibody Fragments Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global F(ab) Fragment Consumption and Growth Rate (2017-2022)
-
Figure Global F(ab’)2 Fragment Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Immunodeficiencies Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global F(ab) Fragment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global F(ab’)2 Fragment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunodeficiencies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antibody Fragments Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antibody Fragments Export by Region (Top 5 Countries) (2017-2028)
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Antibody Fragments Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Antibody Fragments Product and Service
-
Table Takeda Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Antibody Fragments Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Antibody Fragments Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antibody Fragments Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antibody Fragments Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Antibody Fragments Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antibody Fragments Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Antibody Fragments Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Antibody Fragments Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Antibody Fragments Product and Service
-
